# MILESTONE SCIENTIFIC INC. (MLSS) — capital_raise/private_placement [announced]
Source: SEC API (secapi.ai) · situation sit_53f4f280bb02d269426b · retrieved 2026-08-11T16:15:44.654Z

## Overview
Milestone Scientific Inc. manufactures orthopedic, prosthetic, and surgical appliances and supplies.

On July 24, 2026, Milestone Scientific Inc. received conversion notices from three directors—Benedetta Casamento, Dr. Didier Demesmin, and Neal Goldman—electing to convert the remaining outstanding principal and accrued interest under their convertible bridge notes into common stock. The convertible bridge notes were originally issued in an aggregate principal amount of $800,000 and were partially converted on April 20, 2026 in connection with a private placement. The remaining outstanding principal amounts subject to conversion are $116,495.47 (Casamento), $58,247.73 (Demesmin), and $291,238.66 (Goldman), totaling $465,981.86. The conversions will become effective automatically when the fair value of common stock reaches $0.50 per share and the applicable holder is permitted to trade under the company's insider trading policy. No shares have been issued as of the filing date.

## Terms
- Counterparty: Benedetta Casamento, Dr. Didier Demesmin, Neal Goldman · Consideration: stock · Price/share: $0.5

## Key dates
- Announced 2026-07-29

## Timeline
- 2026-07-29 · 8-K (0001493152-26-035264): 8-K - MILESTONE SCIENTIFIC INC. — *Milestone Scientific Inc. manufactures orthopedic, prosthetic, and surgical appliances and supplies.* On July 24, 2026, Milestone Scientific Inc. received conversion notices from three directors—Benedetta Casamento, Dr. Didier Demesmin, and Neal Goldman—electing to convert the remaining outstanding principal and accrued interest under their convertible bridge notes into common stock. The convertible bridge notes were originally issued in an aggregate principal amount of $800,000 and were partially converted on April 20, 2026 in connection with a private placement. The remaining outstanding principal amounts subject to conversion are $116,495.47 (Casamento), $58,247.73 (Demesmin), and $291,238.66 (Goldman), totaling $465,981.86. The conversions will become effective automatically when the fair value of common stock reaches $0.50 per share and the applicable holder is permitted to trade under the company's insider trading policy. No shares have been issued as of the filing date.
  https://www.sec.gov/Archives/edgar/data/855683/0001493152-26-035264.txt

## Citations
- 0001493152-26-035264 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226035264